Figure 6
Figure 6. Sequential acquisition of KIR during NK cell differentiation. In vitro differentiation of NK cells from hematopoietic stem cells was performed as described in “Methods.” RT-PCR results from a donor with KIR genotype 5 (KIR2DL2+KIR2DL3−; A) and a donor with KIR genotype 1 (KIR2DL2−KIR2DL3+; B). Neural cell adhesion molecule (NCAM, CD56) intensity was used as correlate for NK cell development, β-actin as positive control for PCR. (C) Expression levels of KIR2DL1, KIR2DL2, KIR2DL3, and NCAM normalized against β-actin from a donor with KIR genotype 7 (KIR2DL2+KIR2DL3+) were measured with real-time PCR. NCAM levels greater than 600 are indicated.

Sequential acquisition of KIR during NK cell differentiation. In vitro differentiation of NK cells from hematopoietic stem cells was performed as described in “Methods.” RT-PCR results from a donor with KIR genotype 5 (KIR2DL2+KIR2DL3; A) and a donor with KIR genotype 1 (KIR2DL2KIR2DL3+; B). Neural cell adhesion molecule (NCAM, CD56) intensity was used as correlate for NK cell development, β-actin as positive control for PCR. (C) Expression levels of KIR2DL1, KIR2DL2, KIR2DL3, and NCAM normalized against β-actin from a donor with KIR genotype 7 (KIR2DL2+KIR2DL3+) were measured with real-time PCR. NCAM levels greater than 600 are indicated.

Close Modal

or Create an Account

Close Modal
Close Modal